Finerenone for Diabetic Kidney Disease in Type 1 Diabetes — A Fine Answer?
This NEJM editorial discussed the implications of finerenone for diabetic kidney disease in type 1 diabetes, evaluating whether the cardiorenal benefit extends beyond the type 2 diabetes population.
Summary
New England Journal of Medicine, Volume 394, Issue 10, Page 1019-1020, March 5, 2026.
Join us
Join the Global Primary Care Cardio Network. Membership is free.
Would you like to tell us more about yourself?
Interests
We will send you an email with a link to confirm your registration.
